
|Articles|November 1, 2004
New Fillers Coming to America
Only Hylaform was available until the U.S. Food and Drug Administration recently approved Hylaform Plus for treatment of moderate to severe facial wrinkles and folds.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Next-Generation IL-4Rα Targeting and Potential Dermatologic Implications
2
Comparative Analysis Positions Zasocitinib Among Next-Generation TYK2 Inhibitors
3
Utilizing CYP2C9 Testing and JAK Inhibitors for Alopecia Areata
4
Timing, Severity, and Therapeutic Choice in Moderate to Severe HS
5


















